Clinical and laboratory findings with giant cell arteritis
Identifieur interne : 000238 ( Istex/Corpus ); précédent : 000237; suivant : 000239Clinical and laboratory findings with giant cell arteritis
Auteurs : Peter BerlitSource :
- Journal of the Neurological Sciences [ 0022-510X ] ; 1992.
Abstract
Out of 66 patients who were diagnosed as suffering from polymyalgia rheumatica (PMR; n = 40), temporal arteritis (AT;n = 14) or both (n = 12) in a 6.5 year period (incidence 3.4/100 000 per year), 9 died and 49 were followed up for an average period of 28 months. Exacerbations of the illness (n = 24) and complications in the course (n = 32) were more frequent with an initial ESR > 90 mm/h. Postural vertigo (n = 11), amaurosis fugax (n = 11) and polyneuropathy (n = 8) were the most frequent neurological complications. Persisting unilateral blindness and aromatic anosmia developed in 2 patients each. Complications were significantly more frequent in patients with initial symptoms of AT (χ2P < 0.001). CRP-levels correlated better with persisting symptoms in the course than did the ESR. Recurrences after treatment were significantly more frequent when the length of corticosteroid-therapy was less than 20 months (χ2P < 0.009). On follow up there were normal values for neopterin, tumour necrosis factor and antibodies against Borrelia burgdorferi.
Url:
DOI: 10.1016/0022-510X(92)90105-T
Links to Exploration step
ISTEX:CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Clinical and laboratory findings with giant cell arteritis</title><author><name sortKey="Berlit, Peter" sort="Berlit, Peter" uniqKey="Berlit P" first="Peter" last="Berlit">Peter Berlit</name><affiliation><mods:affiliation>Neurological Clinic Mannheim, University of Heidelberg, Mannheim, Germany</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4</idno><date when="1992" year="1992">1992</date><idno type="doi">10.1016/0022-510X(92)90105-T</idno><idno type="url">https://api.istex.fr/document/CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000238</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000238</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Clinical and laboratory findings with giant cell arteritis</title><author><name sortKey="Berlit, Peter" sort="Berlit, Peter" uniqKey="Berlit P" first="Peter" last="Berlit">Peter Berlit</name><affiliation><mods:affiliation>Neurological Clinic Mannheim, University of Heidelberg, Mannheim, Germany</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the Neurological Sciences</title><title level="j" type="abbrev">JNS</title><idno type="ISSN">0022-510X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1992">1992</date><biblScope unit="volume">111</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="1">1</biblScope><biblScope unit="page" to="12">12</biblScope></imprint><idno type="ISSN">0022-510X</idno></series><idno type="istex">CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4</idno><idno type="DOI">10.1016/0022-510X(92)90105-T</idno><idno type="PII">0022-510X(92)90105-T</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-510X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Out of 66 patients who were diagnosed as suffering from polymyalgia rheumatica (PMR; n = 40), temporal arteritis (AT;n = 14) or both (n = 12) in a 6.5 year period (incidence 3.4/100 000 per year), 9 died and 49 were followed up for an average period of 28 months. Exacerbations of the illness (n = 24) and complications in the course (n = 32) were more frequent with an initial ESR > 90 mm/h. Postural vertigo (n = 11), amaurosis fugax (n = 11) and polyneuropathy (n = 8) were the most frequent neurological complications. Persisting unilateral blindness and aromatic anosmia developed in 2 patients each. Complications were significantly more frequent in patients with initial symptoms of AT (χ2P < 0.001). CRP-levels correlated better with persisting symptoms in the course than did the ESR. Recurrences after treatment were significantly more frequent when the length of corticosteroid-therapy was less than 20 months (χ2P < 0.009). On follow up there were normal values for neopterin, tumour necrosis factor and antibodies against Borrelia burgdorferi.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Peter Berlit</name><affiliations><json:string>Neurological Clinic Mannheim, University of Heidelberg, Mannheim, Germany</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Giant cell arteritis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Amaurosis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Corticosteroids</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Temporal artery biopsy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Polyneuropathy</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Out of 66 patients who were diagnosed as suffering from polymyalgia rheumatica (PMR; n = 40), temporal arteritis (AT;n = 14) or both (n = 12) in a 6.5 year period (incidence 3.4/100 000 per year), 9 died and 49 were followed up for an average period of 28 months. Exacerbations of the illness (n = 24) and complications in the course (n = 32) were more frequent with an initial ESR > 90 mm/h. Postural vertigo (n = 11), amaurosis fugax (n = 11) and polyneuropathy (n = 8) were the most frequent neurological complications. Persisting unilateral blindness and aromatic anosmia developed in 2 patients each. Complications were significantly more frequent in patients with initial symptoms of AT (χ2P > 0.001). CRP-levels correlated better with persisting symptoms in the course than did the ESR. Recurrences after treatment were significantly more frequent when the length of corticosteroid-therapy was less than 20 months (χ2P > 0.009). On follow up there were normal values for neopterin, tumour necrosis factor and antibodies against Borrelia burgdorferi.</abstract><qualityIndicators><score>7.064</score><pdfVersion>1.2</pdfVersion><pdfPageSize>612 x 828 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>5</keywordCount><abstractCharCount>1056</abstractCharCount><pdfWordCount>8745</pdfWordCount><pdfCharCount>53464</pdfCharCount><pdfPageCount>12</pdfPageCount><abstractWordCount>172</abstractWordCount></qualityIndicators><title>Clinical and laboratory findings with giant cell arteritis</title><pii><json:string>0022-510X(92)90105-T</json:string></pii><genre><json:string>research-article</json:string></genre><serie><pages><last>1196</last><first>1189</first></pages><genre></genre><language><json:string>unknown</json:string></language><title>Textbook of Rheumatology</title></serie><host><volume>111</volume><pii><json:string>S0022-510X(00)X0249-3</json:string></pii><pages><last>12</last><first>1</first></pages><issn><json:string>0022-510X</json:string></issn><issue>1</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>Journal of the Neurological Sciences</title><publicationDate>1992</publicationDate></host><categories><wos><json:string>CLINICAL NEUROLOGY</json:string><json:string>NEUROIMAGING</json:string><json:string>NEUROSCIENCES</json:string></wos></categories><publicationDate>1992</publicationDate><copyrightDate>1992</copyrightDate><doi><json:string>10.1016/0022-510X(92)90105-T</json:string></doi><id>CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4/fulltext/pdf</uri></json:item><json:item><original>true</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4/fulltext/txt</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Clinical and laboratory findings with giant cell arteritis</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1992</date></publicationStmt><notesStmt><note type="content">Section title: Review article</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Clinical and laboratory findings with giant cell arteritis</title><author><persName><forename type="first">Peter</forename><surname>Berlit</surname></persName><note type="correspondence"><p>Correspondence to: Prof. Dr. P. Berlit, Neurologische Klinik, Alfried Krupp von Bohlen und Halbach Krankenhaus, Alfried Krupp Straβe 21, D-4300 Essen 1, Germany.</p></note><affiliation>Neurological Clinic Mannheim, University of Heidelberg, Mannheim, Germany</affiliation></author></analytic><monogr><title level="j">Journal of the Neurological Sciences</title><title level="j" type="abbrev">JNS</title><idno type="pISSN">0022-510X</idno><idno type="PII">S0022-510X(00)X0249-3</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1992"></date><biblScope unit="volume">111</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="1">1</biblScope><biblScope unit="page" to="12">12</biblScope></imprint></monogr><idno type="istex">CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4</idno><idno type="DOI">10.1016/0022-510X(92)90105-T</idno><idno type="PII">0022-510X(92)90105-T</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1992</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Out of 66 patients who were diagnosed as suffering from polymyalgia rheumatica (PMR; n = 40), temporal arteritis (AT;n = 14) or both (n = 12) in a 6.5 year period (incidence 3.4/100 000 per year), 9 died and 49 were followed up for an average period of 28 months. Exacerbations of the illness (n = 24) and complications in the course (n = 32) were more frequent with an initial ESR > 90 mm/h. Postural vertigo (n = 11), amaurosis fugax (n = 11) and polyneuropathy (n = 8) were the most frequent neurological complications. Persisting unilateral blindness and aromatic anosmia developed in 2 patients each. Complications were significantly more frequent in patients with initial symptoms of AT (χ2P < 0.001). CRP-levels correlated better with persisting symptoms in the course than did the ESR. Recurrences after treatment were significantly more frequent when the length of corticosteroid-therapy was less than 20 months (χ2P < 0.009). On follow up there were normal values for neopterin, tumour necrosis factor and antibodies against Borrelia burgdorferi.</p></abstract><textClass><keywords scheme="keyword"><list><head>Keywords</head><item><term>Giant cell arteritis</term></item><item><term>Amaurosis</term></item><item><term>Corticosteroids</term></item><item><term>Temporal artery biopsy</term></item><item><term>Polyneuropathy</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1992-02-05">Registration</change><change when="1992-01-06">Modified</change><change when="1992">Published</change></revisionDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" </istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="fla"><item-info><jid>JNS</jid><aid>90105</aid><ce:pii>0022-510X(92)90105-T</ce:pii><ce:doi>10.1016/0022-510X(92)90105-T</ce:doi><ce:copyright type="unknown" year="1992"></ce:copyright></item-info><head><ce:dochead><ce:textfn>Review article</ce:textfn></ce:dochead><ce:title>Clinical and laboratory findings with giant cell arteritis</ce:title><ce:author-group><ce:author><ce:given-name>Peter</ce:given-name><ce:surname>Berlit</ce:surname><ce:cross-ref refid="COR1"><ce:sup>∗</ce:sup></ce:cross-ref></ce:author><ce:affiliation><ce:textfn>Neurological Clinic Mannheim, University of Heidelberg, Mannheim, Germany</ce:textfn></ce:affiliation><ce:correspondence id="COR1"><ce:label>∗</ce:label><ce:text>Correspondence to: Prof. Dr. P. Berlit, Neurologische Klinik, Alfried Krupp von Bohlen und Halbach Krankenhaus, Alfried Krupp Straβe 21, D-4300 Essen 1, Germany.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="12" month="7" year="1991"></ce:date-received><ce:date-revised day="6" month="1" year="1992"></ce:date-revised><ce:date-accepted day="5" month="2" year="1992"></ce:date-accepted><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para id="SP0005">Out of 66 patients who were diagnosed as suffering from polymyalgia rheumatica (PMR; <ce:italic>n</ce:italic> = 40), temporal arteritis (AT;<ce:italic>n</ce:italic> = 14) or both (<ce:italic>n</ce:italic> = 12) in a 6.5 year period (incidence 3.4/100 000 per year), 9 died and 49 were followed up for an average period of 28 months. Exacerbations of the illness (<ce:italic>n</ce:italic> = 24) and complications in the course (<ce:italic>n</ce:italic> = 32) were more frequent with an initial ESR > 90 mm/h. Postural vertigo (<ce:italic>n</ce:italic> = 11), amaurosis fugax (<ce:italic>n</ce:italic> = 11) and polyneuropathy (<ce:italic>n</ce:italic> = 8) were the most frequent neurological complications. Persisting unilateral blindness and aromatic anosmia developed in 2 patients each. Complications were significantly more frequent in patients with initial symptoms of AT (<ce:italic>χ</ce:italic><ce:sup>2</ce:sup><ce:italic>P</ce:italic> < 0.001). CRP-levels correlated better with persisting symptoms in the course than did the ESR. Recurrences after treatment were significantly more frequent when the length of corticosteroid-therapy was less than 20 months (<ce:italic>χ</ce:italic><ce:sup>2</ce:sup><ce:italic>P</ce:italic> < 0.009). On follow up there were normal values for neopterin, tumour necrosis factor and antibodies against <ce:italic>Borrelia burgdorferi</ce:italic>.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Giant cell arteritis</ce:text></ce:keyword><ce:keyword><ce:text>Amaurosis</ce:text></ce:keyword><ce:keyword><ce:text>Corticosteroids</ce:text></ce:keyword><ce:keyword><ce:text>Temporal artery biopsy</ce:text></ce:keyword><ce:keyword><ce:text>Polyneuropathy</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Clinical and laboratory findings with giant cell arteritis</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Clinical and laboratory findings with giant cell arteritis</title></titleInfo><name type="personal"><namePart type="given">Peter</namePart><namePart type="family">Berlit</namePart><affiliation>Neurological Clinic Mannheim, University of Heidelberg, Mannheim, Germany</affiliation><description>Correspondence to: Prof. Dr. P. Berlit, Neurologische Klinik, Alfried Krupp von Bohlen und Halbach Krankenhaus, Alfried Krupp Straβe 21, D-4300 Essen 1, Germany.</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1992</dateIssued><dateValid encoding="w3cdtf">1992-02-05</dateValid><dateModified encoding="w3cdtf">1992-01-06</dateModified><copyrightDate encoding="w3cdtf">1992</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Out of 66 patients who were diagnosed as suffering from polymyalgia rheumatica (PMR; n = 40), temporal arteritis (AT;n = 14) or both (n = 12) in a 6.5 year period (incidence 3.4/100 000 per year), 9 died and 49 were followed up for an average period of 28 months. Exacerbations of the illness (n = 24) and complications in the course (n = 32) were more frequent with an initial ESR > 90 mm/h. Postural vertigo (n = 11), amaurosis fugax (n = 11) and polyneuropathy (n = 8) were the most frequent neurological complications. Persisting unilateral blindness and aromatic anosmia developed in 2 patients each. Complications were significantly more frequent in patients with initial symptoms of AT (χ2P < 0.001). CRP-levels correlated better with persisting symptoms in the course than did the ESR. Recurrences after treatment were significantly more frequent when the length of corticosteroid-therapy was less than 20 months (χ2P < 0.009). On follow up there were normal values for neopterin, tumour necrosis factor and antibodies against Borrelia burgdorferi.</abstract><note type="content">Section title: Review article</note><subject><genre>Keywords</genre><topic>Giant cell arteritis</topic><topic>Amaurosis</topic><topic>Corticosteroids</topic><topic>Temporal artery biopsy</topic><topic>Polyneuropathy</topic></subject><relatedItem type="host"><titleInfo><title>Journal of the Neurological Sciences</title></titleInfo><titleInfo type="abbreviated"><title>JNS</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">199208</dateIssued></originInfo><identifier type="ISSN">0022-510X</identifier><identifier type="PII">S0022-510X(00)X0249-3</identifier><part><date>199208</date><detail type="volume"><number>111</number><caption>vol.</caption></detail><detail type="issue"><number>1</number><caption>no.</caption></detail><extent unit="issue pages"><start>1</start><end>118</end></extent><extent unit="pages"><start>1</start><end>12</end></extent></part></relatedItem><identifier type="istex">CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4</identifier><identifier type="DOI">10.1016/0022-510X(92)90105-T</identifier><identifier type="PII">0022-510X(92)90105-T</identifier><recordInfo><recordContentSource>ELSEVIER</recordContentSource></recordInfo></mods></metadata></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/MagnificatV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000238 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000238 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= MagnificatV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:CD71AC51E4E3A2FC4491CE49C5F4A16C9ED1A1F4
|texte= Clinical and laboratory findings with giant cell arteritis
}}
| This area was generated with Dilib version V0.6.31. |  |